
Eloralintide
Eloralintide (LY3841136) is Lilly's once-weekly amylin receptor agonist. Each kit is 10 vials from one batch, 5, 10 or 20 mg a vial.
10 vials from one batchFreeze-dried powder4.8 on Trustpilot
Also known as LY3841136
For research and laboratory use only. Not for human consumption.
- Batch
- Delivery
- Free tracked shipping to 150+ countries. Delivery guaranteed. How delivery works
- Report
- Batch report after the first test · Delivery photos
- Guarantee
- Once this compound's first Certificate of Analysis is published at /lab-results, the same below-COA-purity reship guarantee applies.
- Help
- A person answers on WhatsApp, even at 3 a.m. your time.
Eloralintide: Key Facts
Eloralintide is a weight loss research peptide supplied by LyzeLabs as a lyophilized reference standard, strictly for laboratory research use. It is available in 3 formats. Batch certificates of analysis are published on the lab-results page as verification completes.
| Compound | Eloralintide |
|---|---|
| Research category | GLP-1 and metabolic |
| Available formats | 5mg*10vials, 10mg*10vials, 20mg*10vials |
| Strength shown | 5 mg |
| Molecular formula | C₂₀₁H₃₁₉N₄₉O₆₅S₂ |
| Molecular weight | 4526 g/mol |
| CAS number | 2883634-40-8 |
| Purity | Published on the lab-results page as verification completes |
| Test method | HPLC + mass spectrometry |
| Certificate of analysis | Published on the lab-results page after the first test |
| Intended use | Laboratory research use only. Not for human consumption. |
| Handling | Supplied lyophilized, store per the stability guide |
Good to know
All ten vials are from one batch. One batch report covers the whole kit, so the first vial matches the last.
Your price drops with every kit. Any mix counts, up to 42% off at 50 kits.
About This Product
What is eloralintide?
Eloralintide is a lab-made copy of amylin, a hormone the pancreas releases with insulin after a meal. Amylin tells the brain you are full. It also slows how fast the stomach empties. Eli Lilly built eloralintide to stay active for days. Its code is LY3841136.
Lilly designed it to favour the amylin receptor. In a 12-week early study, it caused few stomach side effects. In the larger phase 2 trial, nausea and tiredness were the most common ones.
How does eloralintide work?
- Amylin receptors: it switches on the same receptors as natural amylin, in the brain areas that end a meal.
- Fullness: amylin signals make you feel full sooner and slow stomach emptying.
- Long-acting: it stays active for days, so the trials gave it once a week.
What do researchers study it for?
- Obesity and weight control
- Type 2 diabetes with obesity
- Combinations with incretin compounds such as tirzepatide
- How amylin signals control appetite
Key studies
- Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial (Lancet, 2025). Average weight loss ranged from 9% to 20% across the trial's groups at 48 weeks, against 0.4% on placebo.
- Eloralintide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to clinical proof of concept (Mol Metab, 2025). How Lilly designed it, and the first human data supporting once-weekly use.
- Eloralintide, a selective, long-acting amylin receptor agonist for treatment of obesity: Phase 1 proof of concept (Diabetes Obes Metab, 2026). Body weight fell 2.6% to 11.3% in 12 weeks, with few stomach side effects.
Status (November 2026)
Eloralintide is investigational. It is not an approved medicine anywhere. Lilly began its phase 3 program, ENLIGHTEN, in February 2026.
Quality Standards
- Form: freeze-dried powder in sealed vials
- Storage: refrigerator for near-term use, minus 20 degrees Celsius long-term
- Batch report: goes up on /lab-results once testing of the first batch is complete
Related research
- Cagrilintide, another long-acting amylin analog, and Cagrilintide + Semaglutide.
- Retatrutide and Tirzepatide, the incretin compounds amylin analogs are tested alongside.
- Survodutide vs mazdutide vs retatrutide: how the next weight-loss compounds compare.
For research purposes only. Not for human consumption or therapeutic use.
Research Context for Eloralintide
Metabolic and Weight Loss Research Context
This compound sits in the incretin and metabolic peptide class, where research focuses on appetite regulation, glucose handling, energy expenditure, and the complex signaling network that connects gut, pancreas, liver, and hypothalamus. Research protocols in this category typically involve dose escalation, tolerability mapping, and long-duration observation of metabolic endpoints.
Eloralintide ships as a lyophilized research reagent through the LyzeLabs™ catalog in the GLP-1 and metabolic category, with 3 variant options sized to different research protocols. Verified LyzeLabs compounds publish their full HPLC chromatogram and mass spectrometry confirmation for each batch on the LyzeLabs lab results page; this compound's analytical data is published there as it completes verification.
Related Research Guides
Retatrutide vs Tirzepatide vs Semaglutide
Full receptor-level comparison of the three leading metabolic peptides with a decision framework for research protocols.
How to Read a Peptide Certificate of Analysis
The verification routine every research lab should run before accepting a vial.
How to Reconstitute a Research Peptide
The nine-step procedure, common mistakes, and per-compound notes for clean reconstitution.
Other Compounds in the GLP-1 and metabolic Category
Research Tools for This Compound
Frequently Asked Questions
What is eloralintide?
A lab-made, long-acting copy of amylin, the fullness hormone the pancreas releases with insulin. Eli Lilly developed it under the code LY3841136.
Is eloralintide approved?
No. As of November 2026 it is investigational, and its phase 3 trials began in February 2026. The eloralintide sold here is research material for laboratory use only.
Eloralintide vs cagrilintide: what is the difference?
Both are long-acting amylin analogs. Cagrilintide, from Novo Nordisk, acts on both amylin and calcitonin receptors. Eloralintide, from Eli Lilly, was designed to favour the amylin receptor.
How much weight loss was seen in trials?
In the 48-week phase 2 trial published in The Lancet, average weight loss ranged from 9% to 20% across the trial's groups, against 0.4% with placebo.
What comes in a eloralintide kit?
Ten sealed vials of freeze-dried eloralintide, all from one batch, at 5 mg, 10 mg or 20 mg a vial.
How should eloralintide be stored?
Keep the sealed vials at -20°C. Once mixed, keep it at 2 to 8°C and use it within 14 days.
How does eloralintide ship?
Eloralintide ships as a freeze-dried powder in sealed vials, which stays stable at room temperature for the trip. Every order goes out in plain packaging with tracking, and most arrive in 7 to 14 days. Store it in the freezer at -20°C once it arrives.
1 kit
$685